Skip to main content
. Author manuscript; available in PMC: 2020 Sep 24.
Published in final edited form as: Biol Blood Marrow Transplant. 2013 Aug 13;19(10):1509–1513. doi: 10.1016/j.bbmt.2013.08.001

Table 1.

Patient Characteristics

Characteristic n
No. of patients 111
Age, median (range), yr. 50 (19 to 71)
Female/male 40/71
Histological Findings
 Non-Hodgkins lymphoma 70
  Indolent 17
  Aggressive 53
 Hodgkin lymphoma 12
 Multiple myeloma 16
 AML/MDS 4
 CML 3
 Other 6
No. of prior regimens, median (range) 3 (0 to 7)
Disease status at enrollment
 Chemosensitive 58
 Chemoresistant 51
CMV status of recipient
 Negative 48
 Positive 63
  Minor ABO mismatch 76
  Major ABO mismatch 22
Risk of relapse
 Low 23
 Medium 18
 High 66

AML indicates acute myelogenous leukemia; MDS, myelodysplastic syndrome; CML, chronic myelogenous leukemia; CMV, cytomegalovirus. Data are presented as n unless otherwise indicated.